Clinical trials
Recruiting Observational Primary Myelofibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| UNC Lineberger Comprehensive Cancer Center | 2 |
| Bristol-Myers Squibb | 1 |
| Center for International Blood and Marrow Transplant Research | 1 |
| FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 1 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |
| MPN Research Foundation | 1 |
| Massive Bio, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 20 |
| Myeloproliferative Disorders | 8 |
| Thrombocythemia, Essential | 8 |
| Polycythemia Vera | 7 |
| Leukemia | 5 |
| Myelodysplastic Syndromes | 4 |
| Blast Crisis | 3 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 3 |
| Lymphoma, B-Cell, Marginal Zone | 3 |
| Lymphoma, Follicular | 3 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.